首页> 外文期刊>Pharmaceutics >Ucuùba ( Virola surinamensis ) Fat-Based Nanostructured Lipid Carriers for Nail Drug Delivery of Ketoconazole: Development and Optimization Using Box-Behnken Design
【24h】

Ucuùba ( Virola surinamensis ) Fat-Based Nanostructured Lipid Carriers for Nail Drug Delivery of Ketoconazole: Development and Optimization Using Box-Behnken Design

机译:Ucuùba(Virola surinamensis)脂肪基纳米结构脂质载体用于酮康唑的指甲药物递送:使用Box-Behnken设计进行开发和优化

获取原文
           

摘要

Ucuùba fat is fat obtained from a plant found in South America, mainly in Amazonian Brazil. Due to its biocompatibility and bioactivity, Ucuùba fat was used for the production of ketoconazole-loaded nanostructured lipid carriers (NLC) in view of an application for the treatment of onychomycosis and other persistent fungal infections. The development and optimization of Ucuùba fat-based NLC were performed using a Box-Behnken design of experiments. The independent variables were surfactant concentration (% w / v ), liquid lipids concentration (% w / v ), solid lipids concentration (% w / v ), while the outputs of interest were particle size, polydispersity index (PDI) and drug encapsulation efficiency (EE). Ucuùba fat-based NLC were produced and the process was optimized by the development of a predictive mathematical model. Applying the model, two formulations with pre-determined particle size, i.e., 30 and 85 nm, were produced for further evaluation. The optimized formulations were characterized and showed particle size in agreement to the predicted value, i.e., 33.6 nm and 74.6 nm, respectively. The optimized formulations were also characterized using multiple techniques in order to investigate the solid state of drug and excipients (DSC and XRD), particle morphology (TEM), drug release and interactions between the formulation components (FTIR). Furthermore, particle size, surface charge and drug loading efficiency of the formulations were studied during a one-month stability study and did not show evidence of significant modification.
机译:乌库巴(Ucuùba)脂肪是从南美(主要在巴西亚马逊河)发现的植物中获得的脂肪。由于其生物相容性和生物活性,鉴于其在治疗甲癣和其他持续性真菌感染中的应用,Ucuùba脂肪用于生产酮康唑负载的纳米结构脂质载体(NLC)。 Ucuùba脂肪基NLC的开发和优化使用Box-Behnken实验设计进行。自变量是表面活性剂浓度(%w / v),液体脂质浓度(%w / v),固体脂质浓度(%w / v),而感兴趣的输出是粒径,多分散指数(PDI)和药物包封效率(EE)。制备了乌库巴基于脂肪的NLC,并通过开发预测性数学模型对过程进行了优化。应用该模型,制备了具有预定粒径(即30和85nm)的两种制剂用于进一步评估。对优化的制剂进行表征,并显示出与预测值一致的粒径,即分别为33.6nm和74.6nm。为了研究药物和赋形剂的固态(DSC和XRD),颗粒形态(TEM),药物释放以及制剂成分之间的相互作用(FTIR),还使用多种技术对优化的制剂进行了表征。此外,在为期一个月的稳定性研究中对制剂的粒径,表面电荷和载药效率进行了研究,但没有显示出明显的修饰迹象。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号